BACKGROUND: Chronic posttraumatic stress disorder (PTSD) can result in significant social and physical impairments. Despite the Department of Veterans Affairs' (VA) expansion of mental health services into primary care clinics to reach larger numbers of Veterans with PTSD, many do not receive sufficient treatment to clinically benefit. This study explored whether the odds of premature mental health treatment termination varies by patient race/ethnicity and, if so, whether such variation is associated with differential access to services or beliefs about mental health treatments. METHODS: Prospective national cohort study of VA patients who were recently diagnosed with PTSD (n = 6,788). Self-administered surveys and electronic VA databases were utilized to examine mental health treatment retention across racial/ethnic groups in the 6 months following the PTSD diagnosis controlling for treatment need, access factors, age, gender, treatment beliefs, and facility factors. RESULTS: African American and Latino Veterans were less likely to receive a minimal trial of pharmacotherapy and African American Veterans were less likely to receive a minimal trial of any treatment in the 6 months after being diagnosed with PTSD. Controlling for beliefs about mental health treatments diminished the lower odds of pharmacotherapy retention among Latino but not African American Veterans. Access factors did not contribute to treatment retention disparities. CONCLUSIONS: Even in safety-net healthcare systems like VA, racial and ethnic disparities in mental health treatment occur. To improve treatment equity, clinicians may need to more directly address patients' treatment beliefs. More understanding is needed to address the treatment disparity for African American Veterans. Published 2014. This article is a U.S. Government work and is in the public domain in the U.S.A.
BACKGROUND:Chronic posttraumatic stress disorder (PTSD) can result in significant social and physical impairments. Despite the Department of Veterans Affairs' (VA) expansion of mental health services into primary care clinics to reach larger numbers of Veterans with PTSD, many do not receive sufficient treatment to clinically benefit. This study explored whether the odds of premature mental health treatment termination varies by patient race/ethnicity and, if so, whether such variation is associated with differential access to services or beliefs about mental health treatments. METHODS: Prospective national cohort study of VA patients who were recently diagnosed with PTSD (n = 6,788). Self-administered surveys and electronic VA databases were utilized to examine mental health treatment retention across racial/ethnic groups in the 6 months following the PTSD diagnosis controlling for treatment need, access factors, age, gender, treatment beliefs, and facility factors. RESULTS: African American and Latino Veterans were less likely to receive a minimal trial of pharmacotherapy and African American Veterans were less likely to receive a minimal trial of any treatment in the 6 months after being diagnosed with PTSD. Controlling for beliefs about mental health treatments diminished the lower odds of pharmacotherapy retention among Latino but not African American Veterans. Access factors did not contribute to treatment retention disparities. CONCLUSIONS: Even in safety-net healthcare systems like VA, racial and ethnic disparities in mental health treatment occur. To improve treatment equity, clinicians may need to more directly address patients' treatment beliefs. More understanding is needed to address the treatment disparity for African American Veterans. Published 2014. This article is a U.S. Government work and is in the public domain in the U.S.A.
Entities:
Keywords:
PTSD/posttraumatic stress disorder; adherence; ethnicity/race; health services; treatment
Authors: Brian E Bunnell; Tatiana M Davidson; Jennifer R Winkelmann; Jessica L Maples-Keller; Leigh E Ridings; Jennifer Dahne; Samir M Fakhry; Kenneth J Ruggiero Journal: Telemed J E Health Date: 2019-02-07 Impact factor: 3.536
Authors: Tracy Stecker; Leslie Adams; Elizabeth Carpenter-Song; Joanne Nicholson; Nicholas Streltzov; Haiyi Xie Journal: Soc Work Public Health Date: 2016-05-21
Authors: John E Zeber; Karen J Coleman; Heidi Fischer; Tae K Yoon; Brian K Ahmedani; Arne Beck; Samuel Hubley; Zac E Imel; Rebecca C Rossom; Susan M Shortreed; Christine Stewart; Beth E Waitzfelder; Greg E Simon Journal: Depress Anxiety Date: 2017-11-02 Impact factor: 6.505
Authors: Carrie J Nobles; Sarah E Valentine; E David Zepeda; Emily M Ahles; Derri L Shtasel; Luana Marques Journal: J Clin Psychiatry Date: 2017-05 Impact factor: 4.384
Authors: Raul I Garcia; Tamanna Tiwari; Francisco Ramos-Gomez; Brenda Heaton; Mario Orozco; Margaret Rasmussen; Patricia Braun; Michelle Henshaw; Belinda Borrelli; Judith Albino; Courtney Diamond; Christina Gebel; Terrence S Batliner; Judith C Barker; Steven Gregorich; Stuart A Gansky Journal: J Public Health Dent Date: 2016-10-19 Impact factor: 1.821